From 2007 until May 2014, Mr. Seaberg was Founder, Chairman and CEO of NeoChord Inc, a company commercialising technology developed at the Mayo Clinic for the repair of the mitral valve via minimally invasive techniques.
Previously, he was employed by Guidant Corp from 1996 until 2006. During his ten years at Guidant, he served in various executive level positions in sales and marketing, including Director of Bradycardia Marketing for Cardiac Rhythm Management (CRM) and Vice President of Sales for Cardiac Surgery.
In 1991, Mr. Seaberg was a co-founder of ACIST Medical and served as its first President and CEO. He was also the founder and CEO of Seaberg Medical, a regional distributor of implantable cardiovascular devices.
Mr. Seaberg served on the board of Synovis Life Technologies (SYNO) from 2008 until its sale to Baxter Inc in 2012. At various times, he served as Chairman of the nominating and governance committee, member of the audit committee and Chairman of the Board.
Currently, he manages the healthcare consulting practice at Platinum Group and enjoys co-teaching a class at the Carlson School of Business (University of Minnesota) in entrepreneurial studies. He holds a Bachelor of Arts in Speech Communications from the University of Minnesota and a Masters in Business Administration (MBA) from the Carlson School of Management, also at the University of Minnesota.
From 2007 to 2013, Mr. Paterson held senior positions at Merck Serono. In his most recent position he was President of Europe, Canada and Australia. He also held the position of Global Head of Cardio Metabolic Care and General Medicine and was responsible for all aspects of company strategy, including manufacturing strategies, commercial operations and budgets.
Between 2010 and 2012, Mr. Paterson was Head of Emerging Markets including Russia, China, India and Brazil, and was a member of the Executive Board. As President during 2007 until 2010 in Japan, he created Merck Serono Japan and successfully managed all company divisions, launching several major products.
In this capacity, Mr. Paterson served as Chairman of the Board of Merck Serono Japan. Between 1994 and 2005, he was employed by Roche Pharmaceuticals. As Marketing Director in Shanghai, China, he launched eight products during this time, including cardiovascular products.
Mr. Paterson has resided overseas since 1999, having lived in China, Singapore, Korea, Japan, Switzerland and the US. He now lives in Switzerland, where he is CEO and co-founder of a software company that provides solutions to the global pharmaceutical industry.
Mr. Paterson holds a MBA from the University of Southern Queensland, and a degree in business studies from the Queensland University of Technology. He has also studied business courses at North Western University (Kellog School of Management) in Chicago, IMD Business School in Switzerland, INSEAD in France and Hong Kong University of Technology. ■